Anti-GGT7 antibody [EPR24550-76]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal GGT7 antibody. Suitable for WB and reacts with Human samples.
View Alternative Names
GGTL3, GGTL5, GGT7, Glutathione hydrolase 7, Gamma-glutamyltransferase 7, Gamma-glutamyltransferase-like 3, Gamma-glutamyltransferase-like 5, Gamma-glutamyltranspeptidase 7, GGT 7
- WB
Supplier Data
Western blot - Anti-GGT7 antibody [EPR24550-76] (AB273046)
This blot was developed using a higher sensitivity ECL substrate.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-GGT7 antibody [EPR24550-76] (ab273046)
Lane 1:
U-2 OS (human bone osteosarcoma epithelial cell) transfected with scrambled siRNA control, whole cell lysate at 20 µg
Lane 2:
U-2 OS transfected with GTT7-siRNA, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 70 kDa
Observed band size: 90 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-GGT7 antibody [EPR24550-76] (AB273046)
Blocking and dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-GGT7 antibody [EPR24550-76] (ab273046) at 1/1000 dilution
Lane 1:
Human hypothalamus lysate at 20 µg
Lane 2:
Human hypothalamus treated with PNGase F lysate at 20 µg
Lane 3:
U-87 MG (human glioblastoma-astrocytoma epithelial cell), whole cell lysate at 20 µg
Lane 4:
U-87 MG treated with PNGase F lysate, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 70 kDa
Observed band size: 110 kDa,70 kDa,90 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-GGT7 antibody [EPR24550-76] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com